A positive correlation between the increasing levels of ROS within the mitochondria and enhanced sensitivity of AML cells to FLT3 inhibitors is in line with this defective positive regulation loop connecting FLT3 activity and ROS production[115]. This evidence concerns the gene FLT3 and acute myeloid leukemia.